Progression through mitosis promotes PARP inhibitor-induced cytotoxicity in homologous recombination-deficient cancer cells
出版年份 2017 全文链接
标题
Progression through mitosis promotes PARP inhibitor-induced cytotoxicity in homologous recombination-deficient cancer cells
作者
关键词
-
出版物
Nature Communications
Volume 8, Issue -, Pages 15981
出版商
Springer Nature
发表日期
2017-07-17
DOI
10.1038/ncomms15981
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The SMX DNA Repair Tri-nuclease
- (2017) Haley D.M. Wyatt et al. MOLECULAR CELL
- MultiQC: summarize analysis results for multiple tools and samples in a single report
- (2016) Philip Ewels et al. BIOINFORMATICS
- Cell cycle control of DNA joint molecule resolution
- (2016) Philipp Wild et al. CURRENT OPINION IN CELL BIOLOGY
- Interplay between Fanconi anemia and homologous recombination pathways in genome integrity
- (2016) Johanna Michl et al. EMBO JOURNAL
- Replication fork stability confers chemoresistance in BRCA-deficient cells
- (2016) Arnab Ray Chaudhuri et al. NATURE
- High-Resolution CRISPR Screens Reveal Fitness Genes and Genotype-Specific Cancer Liabilities
- (2015) Traver Hart et al. CELL
- Replication-induced DNA damage after PARP inhibition causes G2delay, and cell line-dependent apoptosis, necrosis and multinucleation
- (2015) Idun Dale Rein et al. CELL CYCLE
- Rif1 Is Required for Resolution of Ultrafine DNA Bridges in Anaphase to Ensure Genomic Stability
- (2015) Rutger C.C. Hengeveld et al. DEVELOPMENTAL CELL
- Replication stress activates DNA repair synthesis in mitosis
- (2015) Sheroy Minocherhomji et al. NATURE
- Gene essentiality and synthetic lethality in haploid human cells
- (2015) V. A. Blomen et al. SCIENCE
- Identification and characterization of essential genes in the human genome
- (2015) T. Wang et al. SCIENCE
- Roles of SLX1-SLX4, MUS81-EME1, and GEN1 in avoiding genome instability and mitotic catastrophe
- (2014) S. Sarbajna et al. GENES & DEVELOPMENT
- Mus81-Mms4 and Yen1 resolve a novel anaphase bridge formed by noncanonical Holliday junctions
- (2014) Jonay García-Luis et al. Nature Communications
- featureCounts: an efficient general purpose program for assigning sequence reads to genomic features
- (2013) Y. Liao et al. BIOINFORMATICS
- How unfinished business from S-phase affects mitosis and beyond
- (2013) Hocine W Mankouri et al. EMBO JOURNAL
- ERCC1 and MUS81–EME1 promote sister chromatid separation by processing late replication intermediates at common fragile sites during mitosis
- (2013) Valeria Naim et al. NATURE CELL BIOLOGY
- MUS81 promotes common fragile site expression
- (2013) Songmin Ying et al. NATURE CELL BIOLOGY
- Mechanisms of resistance to therapies targeting BRCA-mutant cancers
- (2013) Christopher J Lord et al. NATURE MEDICINE
- ZNF365 Promotes Stability of Fragile Sites and Telomeres
- (2013) Y. Zhang et al. Cancer Discovery
- A Distinct Replication Fork Protection Pathway Connects Fanconi Anemia Tumor Suppressors to RAD51-BRCA1/2
- (2012) Katharina Schlacher et al. CANCER CELL
- Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors
- (2012) J. Murai et al. CANCER RESEARCH
- Mre11-Dependent Degradation of Stalled DNA Replication Forks Is Prevented by BRCA2 and PARP1
- (2012) S. Ying et al. CANCER RESEARCH
- Double-Strand Break Repair-Independent Role for BRCA2 in Blocking Stalled Replication Fork Degradation by MRE11
- (2011) Katharina Schlacher et al. CELL
- Single-vector inducible lentiviral RNAi system for oncology target validation
- (2011) Dmitri Wiederschain et al. CELL CYCLE
- The underlying mechanism for the PARP and BRCA synthetic lethality: Clearing up the misunderstandings
- (2011) Thomas Helleday Molecular Oncology
- The relative efficiency of homology-directed repair has distinct effects on proper anaphase chromosome separation
- (2011) Corentin Laulier et al. NUCLEIC ACIDS RESEARCH
- Poly(ADP-Ribose) Polymerase Is Hyperactivated in Homologous Recombination-Defective Cells
- (2010) P. Gottipati et al. CANCER RESEARCH
- Cytokinesis failure occurs in Fanconi anemia pathway–deficient murine and human bone marrow hematopoietic cells
- (2010) Patrizia Vinciguerra et al. JOURNAL OF CLINICAL INVESTIGATION
- Efficacy of Neoadjuvant Cisplatin in Triple-Negative Breast Cancer
- (2010) Daniel P. Silver et al. JOURNAL OF CLINICAL ONCOLOGY
- Poly (ADP-ribose) polymerase (PARP) is not involved in base excision repair but PARP inhibition traps a single-strand intermediate
- (2010) C. E. Strom et al. NUCLEIC ACIDS RESEARCH
- DNA Lesions Induced by Replication Stress Trigger Mitotic Aberration and Tetraploidy Development
- (2010) Yosuke Ichijima et al. PLoS One
- A Mitotic Phosphorylation Feedback Network Connects Cdk1, Plk1, 53BP1, and Chk2 to Inactivate the G2/M DNA Damage Checkpoint
- (2010) Marcel A. T. M. van Vugt et al. PLOS BIOLOGY
- Differential expression analysis for sequence count data
- (2010) Simon Anders et al. GENOME BIOLOGY
- A High-Throughput Pharmaceutical Screen Identifies Compounds with Specific Toxicity against BRCA2-Deficient Tumors
- (2009) B. Evers et al. CLINICAL CANCER RESEARCH
- PARP is activated at stalled forks to mediate Mre11-dependent replication restart and recombination
- (2009) Helen E Bryant et al. EMBO JOURNAL
- Pathologic Complete Response Rates in Young Women With BRCA1-Positive Breast Cancers After Neoadjuvant Chemotherapy
- (2009) Tomasz Byrski et al. JOURNAL OF CLINICAL ONCOLOGY
- Replication stress induces sister-chromatid bridging at fragile site loci in mitosis
- (2009) Kok Lung Chan et al. NATURE CELL BIOLOGY
- Selective Inhibition of BRCA2-Deficient Mammary Tumor Cell Growth by AZD2281 and Cisplatin
- (2008) B. Evers et al. CLINICAL CANCER RESEARCH
- High sensitivity of BRCA1-deficient mammary tumors to the PARP inhibitor AZD2281 alone and in combination with platinum drugs
- (2008) S. Rottenberg et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now